JMM Correspondence

Preliminary evaluation of two rapid antigen assays for novel influenza A (H1N1) virus detection in clinical specimens
At the present time, specific real-time reverse transcription-PCR (rRT-PCR) assays remain the reference method for virological detection of the novel pandemic swine-origin influenza A (H1N1) virus in clinical samples (http:// www.who.int/csr/resources/publications/ swineflu/WHO_Diagnostic_ RecommendationsH1N1_20090521.pdf). The rapid worldwide spread of the virus highlighted the need for influenza diagnostic tests that are rapid, commercially available and readily performed in primary health care settings to detect viral antigens in respiratory clinical samples and so aid clinical management of severe cases and people at risk of complications, such as pregnant women, newborn infants or obese patients. However, the sensitivity and specificity of commercially available rapid enzyme immunoassays are questionable. To assess their sensitivity in detecting novel influenza A (H1N1) virus, we conducted an evaluation of two rapid influenza diagnostic tests (RIDTs), Espline Influenza A&B (Fujirebio) (Fig. 1) . Overall, from the 25 specimens positive for novel influenza A (H1N1) virus, the Espline RIDT detected 16 positive samples, demonstrating a sensitivity of 64 %, whereas only nine positive samples tested positive by the Binax RIDT, corresponding to a sensitivity of 36 % (Fig. 1) . No false-positive results were observed, indicating a specificity of 100 % for both tests. Statistical comparison of these results using the McNemar test (a P-value of ,0.05 was considered statistically significant) showed that the two RIDTs were significantly less sensitive than the molecular method for novel influenza A (H1N1) virus detection (P50.004 and P50.00003, respectively). Moreover, inter-RITD differences were statistically significant since the Espline test appeared to be significantly more sensitive (16/25) in this study than the Binax test (9/25) for the detection of novel influenza A (H1N1) virus from respiratory specimens (P50.02). The positive predictive value was 100 % for both tests since no false-positive result was detected while Espline and Binax RIDTs negative predictive values were 35.7 % and 23.8 %, respectively.
In conclusion, these results showed that the RIDTs were capable of detecting novel Fig. 1 . Viral load and RIDT results for the 25 samples positive for influenza A (H1N1) virus.
influenza A (H1N1) virus directly in respiratory clinical specimens containing high levels of virus corresponding to H1 C t values ,27 or viral loads higher than 1610 7 M gene copies ml 21 . The sensitivity of the rapid antigen tests that we evaluated was estimated at 64 % for Espline and 36 % for Binax when compared to the specific rRT-PCR assay. These results were identical to those previously reported with the same kits for novel and seasonal influenza A (H1N1) virus detection (Chan et al., 2007 (Chan et al., , 2009 Ginocchio et al., 2009) . Moreover, an effect of the storage of the samples on the sensitivity of the RIDTs for detecting low quantities of the target antigens could not be ruled out. 
